Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0904488 on February 22, 2005

Published online before print February 22, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0904488v1
77/5/811    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shikama, Y.
Right arrow Articles by Maruyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shikama, Y.
Right arrow Articles by Maruyama, Y.
(Journal of Leukocyte Biology. 2005;77:811-819.)
© 2005 by Society for Leukocyte Biology

Accumulation of an intron-retained mRNA for granulocyte macrophage-colony stimulating factor receptor common ß chain in neutrophils of myelodysplastic syndromes

Yayoi Shikama*,{dagger},1, Tsutomu Shichishima{dagger}, Isao Matsuoka*, Paul T. Jubinsky{ddagger}, Colin A. Sieff§ and Yukio Maruyama{dagger}

* Department of Pharmacology and
{dagger} First Department of Internal Medicine, Fukushima Medical University, Japan;
{ddagger} Section of Pediatric Hematology/Oncology, Albert Einstein College of Medicine, Bronx, New York; and
§ Department of Pediatric Oncology and Hematology, Dana-Farber Cancer Institute, Boston, Massachusetts

1 Correspondence: Department of Pharmacology and First Department of Internal Medicine, Fukushima Medical University, Fukushima, 960-1295, Japan. E-mail: yayois{at}fmu.ac.jp

We recently identified a reduction in the neutrophil surface expression of common ß chain (ßc) of the receptor for granulocyte macrophage-colony stimulating factor (GM-CSF) in the patients with myelodysplastic syndromes (MDS). To determine the etiology of the impaired ßc expression, ßc mRNA from neutrophilic granulocytes of MDS patients and healthy controls was analyzed by a combination of direct reverse transcriptiase-polymerase chain reaction-based single-strand conformational polymorphism and sequencing. Nine different ßc transcripts were detected, but none was specific for MDS. However, one of the transcripts (ßc79) containing a 79-base intron insertion between exons V and VI was significantly increased in MDS. This 27-kd isoform consisted of the ßc N-terminal 182 amino acids followed by a new 84-amino-acid sequence. ßc79 was overexpressed in all MDS subtypes. No genomic mutations were detected within the intron or at the intron/exon boundaries. The isoform is predominantly located in the cytoplasm by Western blot analysis and was unable to generate high-affinity binding sites or transduce a signal for proliferation when coexpressed with the receptor for human GM-CSF {alpha} chain. Our study suggests that the accumulation of the abnormal ßc transcripts with intron V retention results in the reduction in cell-surface expression of ßc observed in MDS.

Key Words: MDS • GM-CSF receptor • ßc • splice variant • intron retention







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Leukocyte Biology.